Amedisys Inc. and UnitedHealth Group Reach Agreement with DOJ on Proposed Final Judgment for Merger Approval
Amedisys Inc. announced an update regarding its merger with UnitedHealth Group Incorporated. On August 7, 2025, a proposed final judgment was filed with the U.S. District Court for the District of Maryland, agreed upon by both Amedisys and UnitedHealth Group. This judgment aims to resolve opposition from the U.S. Department of Justice and several state Attorneys General to the merger initially announced on June 26, 2023. The judgment, pending court approval, requires the companies to carry out certain divestitures within a specified timeframe. The merger's completion remains contingent on the fulfillment of certain conditions outlined in the merger agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amedisys Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-175190), on August 07, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。